(A) GBM molecular subtype detection through qPCR analysis. Expression level of Mes (black bars) and PN (white bars) markers in parental tumors was calculated according to ΔΔCt method after normalization with TBP and IPO8. Each gene was then compared with its level in white matter of healthy donor brain (dashed line). Expression level in GICs cultures was depicted as normalized mRNA amount (n = 3). GBT, parental tumor. (D) MLPA for genomic copy number aberration of EGFR, PTEN and TP53. Ratios exclusively outside 0.8-1.2 range were accounted for as variations. Data shown are averages of all probes matching within each gene (n = 3). The major genomic alterations found in primary tumor tissues and the matching patient-derived culture pairs were consistent and included loss of PTEN locus and EGFR amplification. Of note, clear amplification of EGFR was detected in GBT82 and GBT104, whereas other samples require further validation. T, parental tumor; G, GICs cultures; D, DGC cultures.
Supplementary Figure 2: Characterization of stem functional features of established GICs cultures
(A) Representative picture of Soft Agar Assay carried out with PG88-DGC and PG88-GICs. Cell seeded for each well is reported: 1000 and 2000 cell/well in PG88s; 1000, 2000, 5000 and 20000 cell/well in PG88. DGC cells had to be seeded 10-times more concentrated than neurospheres to appreciate real colony growth, and still the colonies generated by neurosphere cultures were considerably bigger.
(B) Self-renewal capability of neurosphere cultures. Data are plotted as percentage mean of cells capable of growing as spheres bigger than 100 μm in diameter after 14 days (n = 3 independent experiment).
(C) Immunofluorescence of differentiated PG82-GICs and PG90-GICs for neuronal markers (MAP2 and TUJ1), astrocytic marker (GFAP) and oligodendroglial marker (CNPase). Nuclei are counterstained with Draq5. Scale bar, 10 μm.
(D) Hematoxylin/eosin stain and immunohistochemistry for GFAP, CD44 and Vimentin. Tumor area generated in nude mouse brain following injection with PG82-GICs or PG90-GICs and the corresponding parental tumors were analyzed. Scale bar, 100 µm. Expression levels of the different proteins analyzed in mice and original tumors were found to be consistent.
Supplementary Figure 3: Comparative detection of CSCs markers expression in established cultures
(A) Real-time PCR analysis of CSCs markers L1CAM, ITGA6 and CD44. R-fold was obtained from data processed according to the ΔΔCt method, using corresponding DGC expression level as internal control (n = 3 with unpaired t-test, ** P < .01, *** P < .001).
(B) Western blot quantification of CD44, ITGA6 and L1CAM through densitometric analysis. Data are normalized to β-actin protein level (n = 3 independent samples with unpaired t-test, * P < .05, ** P <.01, *** P < .001). GICs R-fold indicates the fold difference between GICs culture and corresponding DGC. CD44 higher protein expression in GICs cultures was observed, suggesting protein stabilization. (B) Box-plot diagram showing the expression of the indicated genes across the different molecular subtypes of GBM. Data were obtained from the TCGA array platform (AgilentG4502A_07_2) extracted from the TCGA cancer browser (* P < .05, ** P < .01, *** P < .001 with ANOVA in comparison to expression in Mes subtype). Among gene composing the panel PTGS2, LIF, ICAM1, IL6, CTGF and NNMT reported a significantly higher expression in Mes subtype.
(C) Kaplan-Meier curves showing progression-free survival (left) and overall survival (right) of GBM patients with either no expression alteration or upregulation of PTGS2, LIF, ICAM1, IL6, CTGF and NNMT. According to cBioPortal default settings, median PFS was 4.07 months for patients with high expression of the gene set, whereas it was 7.62 months for those with low expression (P < .001). In addition, median OS was 11.83 and 14.62 months for patients with high and low expression, respectively (P < .05). Table S1 . List of genes differentially expressed in cluster 3 versus cluster 2
Genes significantly upregulated or downregulated following double-IR in PG35-GICs-R showing FDR< .05. Indicated nominal p-value was calculated with two-tailed unpaired t-test.
Supplementary Methods

Isolation of GICs from parental tumors
Samples were first rinsed with Hank's Balanced Salt Solution (HBSS), then mechanically dissociated and enzymatically digested with 20 U/ml Papain (Worthington) stabilized with 8.25 M L-Cysteine (Sigma) and 3.42 M EDTA (Panreac) for 30 min at 37ºC with constant agitation, and then cultured in FBS-free media [1] . Neurosphere primary cell cultures were subsequently split 1:10 every 5-7 days by mechanical dissociation and extensively maintained for at least twenty passages. All cultures were maintained at 37°C in a humidified atmosphere with 5% carbon dioxide and were tested for mycoplasma routinely. All experiments were performed before passage 20.
Western blot antibodies employed
The following antibodies were used: anti-L1CAM (1:1000; clone 2C2; Abcam), anti-ITGA6 (1:500; HPA012626; Novus Biologicals), anti-CD44 (1:100; clone 156-3C11; Thermo scientific), anti-β-Actin (1:5000; clone AC-15; Sigma), anti-pSTAT3-Y705 (1:2000; clone D3A7; CST), anti-pSTAT3-S727 (1:500; #78835; RD System) and STAT3 (1:2000; clone 79D7; CST). To avoid false negative signal in monolayer cultures during protein analysis, cells were collected by scraping, thereby avoiding trypsin digestion.
Interpretation of survival curves with the LQM
Surviving fraction (SF) of each treatment dose (D) was obtained according to previously described protocol [2] ; SF data were then fit according to the linear-quadratic model (LQM): SF = exp -(αD+βD 2 ). Differential radiosensitivity was evaluated by means of the surviving fraction after 2 Gy (SF2) and 8 Gy (SF8); the area under the curve (AUC) and the LQM parameters: α-and β-values and α/β [2] [3] [4] .
Methylation-specific PCR
Genomic DNA was isolated from frozen tumor using the Qiamp DNA mini kit (Quiagen). DNA methylation status of CpG islands of the enzyme O6-methylguanine methyltransferase (MGMT) promoter was determined by methylation-specific PCR (MSP) as previously described [5] .
Aberrant genomic copy number detection
Copy numbers of EGFR, TP53 and PTEN were detected through Multiplex Ligation-dependent Probe Amplification (SALSA MLPA Kit P105, MLPA®, Mrc-Holland, The Netherlands). Analysis was carried out on patient tumor tissues (GBT), and primary DGC and GICs cultures. DNA was extracted with Qiamp DNA mini kit (Quiagen), and MLPA was executed following the manufacturer's instructions. MLPA profiles of primary cultures and tumor samples were compared to genomic DNA obtained from healthy donors. Peak areas were analyzed with Coffalyser software (MRC Holland, The Netherlands) considering as normal variation values those falling between 0.8 and 1.2. Ratios below 0.8 were considered as locus deletions. Ratios above 1.2 were considered as amplifications.
Self-renewal assay
For the self-renewal assay, neurospheres were mechanically dissociated and seeded at extremely low cell density (1 cell per well) in a 96-well flat-bottomed plate. After 24 hours, plates were visually scanned with inverted light microscope to select wells containing a single cell. Colony formation was recorded 14 days later and the percentage of growth as neurosphere was determined. Only neurospheres exceeding 100 µm in diameter were counted (ProgRes CapturePro).
Intracranial tumor assay
All mouse experiments were approved by and performed according to the guidelines of the IDIBELL Animal Care Committee in agreement with the European Union and national directives. 1x10 5 GICs were inoculated approximately into the corpus striatum of the right brain hemisphere of 7-week-old male athymic mice (Harlan). After 7 weeks mice were euthanatized, and brains were collected, formalin fixed and paraffin embedded. Immunohistochemistry was performed on 4 μm slices using the following primary antibodies: anti-GFAP (clone 6F2; Dako), anti-vimentin (clone 3B4; Dako) and anti-CD44 (clone 156-3C11; Thermo). Samples were counterstained with hematoxylin. Original patient tumor samples underwent the same procedures.
Immunofluorescence staining DGC and GICs cultures were fixed in 4% paraformaldehyde for 20 min. To perform the analysis of free-floating neurospheres, a variation of the protocol was carried out as previously described [6] . The following antibodies were used: anti-L1CAM (1:1000; clone 2C2; Abcam), anti-ITGA6 (1:100; NKIGoH3; Millipore) and anti-CD44 (1:100; clone 156-3C11; Thermo scientific). Micrographs were captured with a Leica TCS-SL Spectral confocal microscope (Leica Microsystems, Germany). Images were assembled using Adobe Photoshop, with identical adjustments for contrast, brightness and color balance.
Differentiation assay
In order to assess GICs capacity to differentiate along the mayor CNS lineages, cells were seeded and maintained with 10% FBS for 14 days. Samples were then processed for immunofluorescence. The following antibodies were used: anti-MAP2 (1:100; Sigma), anti-CNPase (1:100; Sigma), anti-GFAP (1:50; Dako) and anti-Tuj1 (1:1000; Covance).
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